Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
Rapid Micro Biosystems (Nasdaq: RPID) announced it will release its third quarter 2024 financial results before market open on Friday, November 1, 2024. The company, which provides automation solutions for healthcare product manufacturing, will host a webcast conference call at 9:00 a.m. ET on the same day. The audio webcast will be accessible through the company's website and available for replay for one year.
Rapid Micro Biosystems (Nasdaq: RPID) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 prima dell’apertura del mercato venerdì 1 novembre 2024. L’azienda, che offre soluzioni di automazione per la produzione di prodotti sanitari, ospiterà una conferenza web in diretta alle 9:00 a.m. ET lo stesso giorno. La trasmissione audio sarà accessibile attraverso il sito web dell'azienda e sarà disponibile per la riproduzione per un anno.
Rapid Micro Biosystems (Nasdaq: RPID) anunció que publicará sus resultados financieros del tercer trimestre de 2024 antes de la apertura del mercado el viernes 1 de noviembre de 2024. La compañía, que ofrece soluciones de automatización para la fabricación de productos de salud, llevará a cabo una llamada de conferencia por webcast a las 9:00 a.m. ET el mismo día. La transmisión de audio estará disponible a través del sitio web de la empresa y se podrá reproducir durante un año.
Rapid Micro Biosystems (Nasdaq: RPID)는 2024년 11월 1일 금요일에 시장이 열리기 전에 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 의료 제품 제조를 위한 자동화 솔루션을 제공하는 이 회사는 같은 날 오전 9시(동부 표준시)에 웹캐스트 컨퍼런스 콜을 진행할 예정입니다. 오디오 웹캐스트는 회사 웹사이트를 통해 접근 가능하며 1년 동안 재생할 수 있습니다.
Rapid Micro Biosystems (Nasdaq: RPID) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 avant l'ouverture du marché vendredi 1er novembre 2024. L'entreprise, qui fournit des solutions d'automatisation pour la fabrication de produits de santé, organisera une conférence par webcast à 9h00 ET le même jour. Le webcast audio sera accessible sur le site web de l'entreprise et sera disponible en replay pendant un an.
Rapid Micro Biosystems (Nasdaq: RPID) gab bekannt, dass es seine Finanzergebnisse für das dritte Quartal 2024 vor der Markteröffnung am Freitag, den 1. November 2024, veröffentlichen wird. Das Unternehmen, das Automatisierungslösungen für die Herstellung von Gesundheitsprodukten anbietet, wird am selben Tag um 9:00 Uhr ET eine Webcast-Konferenzschaltung veranstalten. Der Audio-Webcast wird über die Website des Unternehmens zugänglich sein und ein Jahr lang zum Replay verfügbar sein.
- None.
- None.
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024.
In conjunction with the release, the Company’s management team will host a webcast conference call beginning at 9:00 a.m. ET on Friday, November 1, 2024. The live audio webcast will be accessible on the Company’s website here and will be available for replay for one year from the webcast date.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct System automates and modernizes the antiquated, manual MQC testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct System brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered in Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands.
For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.
FAQ
When will Rapid Micro Biosystems (RPID) release Q3 2024 earnings?
What time is RPID's Q3 2024 earnings call?
How long will RPID's Q3 2024 earnings webcast be available for replay?
